ATI RN
ATI Pharmacology Exam 2 Questions
Extract:
Question 1 of 5
A nurse is reviewing the medical record of a client who has hypertension and a new prescription for metoprolol. Which of the following findings should the nurse investigate further?
Correct Answer: C
Rationale: Tadalafil with metoprolol risks hypotension, requiring investigation, unlike heart failure, pneumonia, or diabetes, which are compatible.
Question 2 of 5
A nurse is teaching a client who has a new prescription for transdermal nitroglycerin to treat angina pectoris. Which of the following instructions should the nurse include in the teaching?
Correct Answer: B
Rationale: Applying the patch in the morning maintains nitrate levels during active hours, with a nitrate-free interval at night to prevent tolerance, unlike other options.
Question 3 of 5
A nurse is monitoring a client who is receiving a unit of packed red blood cells (RBCs) following surgery. Which of the following assessments is an indication that the client might be experiencing circulatory overload?
Correct Answer: D
Rationale: Dyspnea indicates circulatory overload from fluid accumulation in the lungs, unlike bradycardia, flushing, or vomiting.
Question 4 of 5
A nurse is caring for a client who has acute respiratory distress syndrome (ARDS) and requires mechanical ventilation. The client receives a prescription for pancuronium. The nurse recognizes that this medication is for which of the following purposes?
Correct Answer: A
Rationale: Pancuronium, a neuromuscular blocker, suppresses respiratory effort to optimize mechanical ventilation in ARDS, unlike compliance, secretions, or sedation.
Question 5 of 5
A nurse is caring for a client who is on warfarin therapy for atrial fibrillation. The client's INR is 5.2. Which of the following medications should the nurse prepare to administer?
Correct Answer: C
Rationale: An INR of 5.2 indicates excessive anticoagulation. Vitamin K reverses warfarin's effects by restoring clotting factor synthesis, unlike atropine, epinephrine, or protamine (heparin antidote).